BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33448852
Number of visits today
6383
Number of downloads
16634015
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Kishida T, Ejima A, Mazda O. Specific Destruction of HIV Proviral p17 Gene in T Lymphoid Cells Achieved by the Genome Editing Technology. Front Microbiol 2016;7:1001. [PMID: 27446041 DOI: 10.3389/fmicb.2016.01001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Abana CZ, Lamptey H, Bonney EY, Kyei GB. HIV cure strategies: which ones are appropriate for Africa? Cell Mol Life Sci 2022;79:400. [PMID: 35794316 DOI: 10.1007/s00018-022-04421-z] [Reference Citation Analysis]
2 Kwarteng A, Ahuno ST, Kwakye-Nuako G. The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther 2017;14:32. [PMID: 28705213 DOI: 10.1186/s12981-017-0157-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
3 Shim G, Kim D, Park GT, Jin H, Suh SK, Oh YK. Therapeutic gene editing: delivery and regulatory perspectives. Acta Pharmacol Sin 2017;38:738-53. [PMID: 28392568 DOI: 10.1038/aps.2017.2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 12.2] [Reference Citation Analysis]
4 Khalili K, White MK, Jacobson JM. Novel AIDS therapies based on gene editing. Cell Mol Life Sci 2017;74:2439-50. [PMID: 28210784 DOI: 10.1007/s00018-017-2479-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345